Mimedx (MDXG) Other Working Capital Changes (2011 - 2026)
Mimedx recorded quarterly Other Working Capital Changes of $118000.0 in Q1 2026, up 20.41% quarter-over-quarter from $98000.0 in Q4 2025, and down 88.57% year-over-year from $1.0 million in Q1 2025.
Mimedx's Other Working Capital Changes history runs 16 years deep, the most recent figure standing at $118000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 88.57% year-over-year to $118000.0; the TTM figure through Mar 2026 stood at -$273000.0 (down 171.28% YoY), while the FY2025 annual figure was $641000.0, up 82.1% from the prior year.
- Other Working Capital Changes came in at $118000.0 for Q1 2026 at Mimedx, up from $98000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q2 2023 to a low of -$1.3 million in Q4 2023.
- A 5-year average of $23588.2 and a median of $118000.0 in 2022 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1017.8% in 2023 and fell as far as 618.43% in 2023.
- Mimedx's Other Working Capital Changes stood at $255000.0 in 2022, then slumped by 618.43% to -$1.3 million in 2023, then surged by 50.91% to -$649000.0 in 2024, then soared by 115.1% to $98000.0 in 2025, then gained by 20.41% to $118000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $118000.0, $98000.0, and $698000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118,000.00 |
| Mar 31, 2026 | 118,000.00 |
| Dec 31, 2025 | 98,000.00 |
| Dec 31, 2025 | 98,000.00 |
| Sep 30, 2025 | 698,000.00 |
| Sep 30, 2025 | 698,000.00 |
| Jun 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -1.19 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | -649,000.00 |
| Dec 31, 2024 | -649,000.00 |
| Sep 30, 2024 | 494,000.00 |
| Sep 30, 2024 | 494,000.00 |
| Jun 30, 2024 | -494,000.00 |
| Jun 30, 2024 | -494,000.00 |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | -1.32 Mn |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | -219,000.00 |
| Sep 30, 2023 | -219,000.00 |
| Jun 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | -1.03 Mn |
| Mar 31, 2023 | -1.03 Mn |
| Dec 31, 2022 | 255,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | -66,000.00 |
| Sep 30, 2022 | -66,000.00 |
| Jun 30, 2022 | 118,000.00 |
| Jun 30, 2022 | 118,000.00 |
| Mar 31, 2022 | 235,000.00 |
| Mar 31, 2022 | 235,000.00 |
| Dec 31, 2021 | -6.46 Mn |
| Dec 31, 2021 | -6.46 Mn |
| Sep 30, 2021 | -1.27 Mn |
| Sep 30, 2021 | -1.27 Mn |
| Jun 30, 2021 | -1.34 Mn |
| Jun 30, 2021 | -1.34 Mn |
| Mar 31, 2021 | -910,000.00 |
| Mar 31, 2021 | -910,000.00 |
| Dec 31, 2020 | 1.75 Mn |
| Dec 31, 2020 | 1.75 Mn |
| Sep 30, 2020 | 2.19 Mn |
| Sep 30, 2020 | 2.19 Mn |
| Jun 30, 2020 | -2.39 Mn |
| Jun 30, 2020 | -2.39 Mn |
| Mar 31, 2020 | -1.43 Mn |
| Mar 31, 2020 | -1.43 Mn |
| Dec 31, 2019 | -3.52 Mn |
| Dec 31, 2019 | -3.52 Mn |
| Sep 30, 2019 | 1.99 Mn |
| Sep 30, 2019 | 1.99 Mn |
| Jun 30, 2019 | 3.58 Mn |
| Jun 30, 2019 | 3.58 Mn |
| Mar 31, 2019 | -2.05 Mn |
| Mar 31, 2019 | -2.05 Mn |
| Dec 31, 2018 | -2.71 Mn |
| Dec 31, 2018 | -2.71 Mn |
| Sep 30, 2018 | -1.04 Mn |
| Sep 30, 2018 | -1.04 Mn |
| Jun 30, 2018 | -860,000.00 |
| Jun 30, 2018 | -860,000.00 |
| Mar 31, 2018 | 1.04 Mn |
| Mar 31, 2018 | 1.04 Mn |
| Dec 31, 2017 | -97,000.00 |
| Dec 31, 2017 | -97,000.00 |
| Sep 30, 2017 | -1.92 Mn |
| Sep 30, 2017 | -1.92 Mn |
| Jun 30, 2017 | 1.34 Mn |
| Jun 30, 2017 | 1.34 Mn |
| Mar 31, 2017 | 984,000.00 |
| Mar 31, 2017 | 984,000.00 |
| Dec 31, 2016 | -456,000.00 |
| Dec 31, 2016 | -456,000.00 |
| Sep 30, 2016 | 242,000.00 |
| Sep 30, 2016 | 242,000.00 |
| Jun 30, 2016 | -285,000.00 |
| Jun 30, 2016 | -285,000.00 |
| Mar 31, 2016 | 2.07 Mn |
| Mar 31, 2016 | 2.07 Mn |
| Dec 31, 2015 | 1.83 Mn |
| Dec 31, 2015 | 1.83 Mn |
| Sep 30, 2015 | -1.08 Mn |
| Sep 30, 2015 | -1.08 Mn |
| Jun 30, 2015 | 1.08 Mn |
| Jun 30, 2015 | 1.08 Mn |
| Mar 31, 2015 | 26,000.00 |
| Mar 31, 2015 | 26,000.00 |
| Dec 31, 2014 | 203,000.00 |
| Dec 31, 2014 | 203,000.00 |
| Sep 30, 2014 | -988,000.00 |
| Sep 30, 2014 | -988,000.00 |
| Jun 30, 2014 | 46,000.00 |
| Jun 30, 2014 | 46,000.00 |
| Mar 31, 2014 | 942,000.00 |
| Mar 31, 2014 | 942,000.00 |
| Dec 31, 2013 | -276,644.00 |
| Dec 31, 2013 | -276,644.00 |
| Sep 30, 2013 | 192,421.00 |
| Sep 30, 2013 | 192,421.00 |
| Jun 30, 2013 | 165,531.00 |
| Jun 30, 2013 | 165,531.00 |
| Mar 31, 2013 | 555,692.00 |
| Mar 31, 2013 | 555,692.00 |
| Dec 31, 2012 | -479,051.00 |
| Dec 31, 2012 | -479,051.00 |
| Sep 30, 2012 | 254,492.00 |
| Sep 30, 2012 | 254,492.00 |
| Jun 30, 2012 | -85,272.00 |
| Jun 30, 2012 | -85,272.00 |
| Mar 31, 2012 | 212,831.00 |
| Mar 31, 2012 | 212,831.00 |
| Dec 31, 2011 | -80,635.00 |
| Dec 31, 2011 | -80,635.00 |
| Sep 30, 2011 | 20,502.00 |
| Sep 30, 2011 | 20,502.00 |
| Jun 30, 2011 | -14,517.00 |
| Jun 30, 2011 | -14,517.00 |
| Mar 31, 2011 | 155,025.00 |
| Mar 31, 2011 | 155,025.00 |